Association of COX2 −765G>C promoter polymorphism and coronary artery disease in Korean population

[31] Witte JS(2007)Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer Carcinogenesis 28 1197-114

[32] Chiang SL(2002)Cyclooxygenase isozymes and their gene structures and expression Prostaglandins Other Lipid Mediat 68–69 95-59

[33] Chen PH(2009)Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma Mutat Res 663 52-10

[34] Lee CH(1998)Differential inhibition of cyclooxygenase isoforms: an explanation of the action of NSAIDs J Clin Rheumatol 4 s3-603

[35] Ko AM(2008)Study on the association of cyclooxygenase-2 -765 G>C and prostacyclin synthase C1117A polymorphisms and the risk of myocardial infarction in Uigur population of Xinjiang, China Zhonghua Liu Xing Bing Xue Za Zhi 29 598-352

[36] Lee KW(2009)Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction Clin Chem Lab Med 47 347-60

[37] Lin YC(2011)Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population Clin Chem Lab Med 49 55-1789

[38] Ho PS(2008)Cyclooxygenase 2 polymorphism and colorectal cancer: − 765G>C variant modifies risk associated with smoking and body mass index World J Gastroenterol 14 1785-2244

[39] Tu HP(2008)Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition Clin Cancer Res 14 2236-576

[40] Wu DC(2005)Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 565-1668

[31] Witte JS(2007)Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer Carcinogenesis 28 1197-114

[32] Chiang SL(2002)Cyclooxygenase isozymes and their gene structures and expression Prostaglandins Other Lipid Mediat 68–69 95-59

[33] Chen PH(2009)Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma Mutat Res 663 52-10

[34] Lee CH(1998)Differential inhibition of cyclooxygenase isoforms: an explanation of the action of NSAIDs J Clin Rheumatol 4 s3-603

[35] Ko AM(2008)Study on the association of cyclooxygenase-2 -765 G>C and prostacyclin synthase C1117A polymorphisms and the risk of myocardial infarction in Uigur population of Xinjiang, China Zhonghua Liu Xing Bing Xue Za Zhi 29 598-352

[36] Lee KW(2009)Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction Clin Chem Lab Med 47 347-60

[37] Lin YC(2011)Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population Clin Chem Lab Med 49 55-1789

[38] Ho PS(2008)Cyclooxygenase 2 polymorphism and colorectal cancer: − 765G>C variant modifies risk associated with smoking and body mass index World J Gastroenterol 14 1785-2244

[39] Tu HP(2008)Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition Clin Cancer Res 14 2236-576

[40] Wu DC(2005)Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 565-1668